Monday, March 17, 2025 | 07:12 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Natco Pharma transfers Lenalidomide Capsules ANDA to Arrow International

Image

Capital Market
Natco Pharma announced that it has transferred the Lenalidomide Capsules ANDA (2.5mg, 5mg, 10mg, 15mg, 20mg and 25mg strengths) to Arrow International as per an earlier agreement between the parties.

This transfer of the ANDA to Arrow does not materially change any of the terms of the agreement between the parties.

Arrow International (an affiliate of Teva Pharmaceutical Industries) is the marketing partner of NATCO for this product in the US market. The ANDA was approved by USFDA in May 2021 with final approval in the 5mg, 10mg, 15mg, and 25mg strengths, and tentative approval in the 2.5mg and 20mg strengths.

 

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 03 2021 | 8:05 PM IST

Explore News